IMRX
Immuneering Corp
4.30$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.9% | -14.2% | -12.4% | -11.1% | -23.1% | -3.9% | -21.0% | +501.8% | -3.8% | -7.4% | -5.9% | |
| – | -11.4% | -16.4% | -14.5% | -13.2% | -28.4% | -3.5% | -27.4% | +726.3% | -23.1% | -8.4% | -2.1% | |
| – | -12.7% | +11.6% | -9.9% | -24.3% | -20.0% | -0.8% | -26.5% | +763.4% | -43.5% | -63.2% | -12.7% | |
| – | -11.9% | -16.8% | -16.2% | -15.2% | -28.6% | -0.8% | -26.5% | +763.4% | -24.1% | -9.3% | -4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -1.9% | -1.9% | -2.0% | -2.0% | -2.0% | -2.1% | -2.1% | -2.2% | -2.2% | -2.3% | -2.3% | |
| – | +21.7% | -22.9% | +16.4% | +0.5% | +4.5% | -22.0% | +25.8% | +17.6% | +3.2% | -38.6% | +36.5% | |
| – | +39.5% | -34.0% | +31.0% | +2.0% | +8.4% | -31.9% | +46.6% | +27.5% | +5.5% | -50.6% | +63.2% | |
| – | -0.5% | -0.5% | +4.3% | +4.3% | +4.2% | +4.2% | +4.1% | +4.0% | +4.0% | +4.0% | +3.9% | |
| – | +8.8% | +7.5% | +15.5% | -25.9% | +0.8% | -33.1% | +82.8% | -33.2% | -3.6% | -5.8% | +132.4% | |
| – | -12.9% | -13.1% | -15.8% | -12.9% | -28.3% | +1.1% | -30.8% | +687.9% | -4.2% | -5.5% | -7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.3% | +1.0% | +0.6% | +4.0% | +14.4% | +1.3% | +10.2% | +62.8% | +0.1% | +0.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.